用多模态深度学习提升口腔癌早期诊断准确率
Multi-Modal Oral Cancer Detection Using Weighted Ensemble Convolutional Neural Networks
- 融合临床、影像和病理图像,用加权集成DenseNet模型进行诊断
- 多模态集成模型准确率达84.58%,其中影像和病理模态分别达100%和95.12%
- 适合医疗AI研究者与口腔科医生参考,助力早期癌症筛查
口腔鳞状细胞癌(OSCC)晚期诊断导致全球高死亡率,超过50%病例在晚期被发现,5年生存率低于50%。本研究旨在通过构建融合临床、放射学和组织病理学图像的多模态深度学习框架,提升早期检测能力。采用迁移学习训练三个模态对应的DenseNet-121 CNN模型,结合数据增强与模态特定预处理以提高鲁棒性。使用验证加权集成策略融合预测结果。评估指标包括准确率、精确率、召回率和F1分数。结果显示,放射学模态验证准确率为100%,组织病理学为95.12%,临床图像因视觉异质性表现较差(63.10%)。集成模型在包含55个样本的多模态验证集上总体准确率达84.58%。该框架提供了一种非侵入性、AI辅助的分诊工具,可提升高风险病灶识别效率,支持临床决策,符合全球肿瘤指南,有助于减少诊断延迟、改善患者预后。
原文摘要 · Abstract (English)
Aims Late diagnosis of Oral Squamous Cell Carcinoma (OSCC) contributes significantly to its high global mortality rate, with over 50\% of cases detected at advanced stages and a 5-year survival rate below 50\% according to WHO statistics. This study aims to improve early detection of OSCC by developing a multimodal deep learning framework that integrates clinical, radiological, and histopathological images using a weighted ensemble of DenseNet-121 convolutional neural networks (CNNs). Material and Methods A retrospective study was conducted using publicly available datasets representing three distinct medical imaging modalities. Each modality-specific dataset was used to train a DenseNet-121 CNN via transfer learning. Augmentation and modality-specific preprocessing were applied to increase robustness. Predictions were fused using a validation-weighted ensemble strategy. Evaluation was performed using accuracy, precision, recall, F1-score. Results High validation accuracy was achieved for radiological (100\%) and histopathological (95.12\%) modalities, with clinical images performing lower (63.10\%) due to visual heterogeneity. The ensemble model demonstrated improved diagnostic robustness with an overall accuracy of 84.58\% on a multimodal validation dataset of 55 samples. Conclusion The multimodal ensemble framework bridges gaps in the current diagnostic workflow by offering a non-invasive, AI-assisted triage tool that enhances early identification of high-risk lesions. It supports clinicians in decision-making, aligning with global oncology guidelines to reduce diagnostic delays and improve patient outcomes.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。